ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,556 | +37320.1% | 80,031 | +42244.4% | 0.01% | – |
| Q2 2023 | $3,839 | -99.7% | 189 | -99.7% | 0.00% | -100.0% |
| Q1 2023 | $1,240,867 | -44.9% | 68,030 | -37.5% | 0.01% | -38.5% |
| Q4 2022 | $2,252,135 | +18.8% | 108,904 | +50.3% | 0.01% | +18.2% |
| Q3 2022 | $1,896,000 | -35.6% | 72,474 | -37.6% | 0.01% | -38.9% |
| Q2 2022 | $2,944,000 | +90.8% | 116,182 | +137.6% | 0.02% | +38.5% |
| Q1 2022 | $1,543,000 | -42.5% | 48,888 | -26.3% | 0.01% | -50.0% |
| Q4 2021 | $2,685,000 | +378.6% | 66,352 | +312.4% | 0.03% | +271.4% |
| Q3 2021 | $561,000 | -30.4% | 16,091 | -45.2% | 0.01% | -22.2% |
| Q2 2021 | $806,000 | +62.8% | 29,357 | +66.6% | 0.01% | +50.0% |
| Q1 2021 | $495,000 | -14.4% | 17,625 | -20.8% | 0.01% | -25.0% |
| Q4 2020 | $578,000 | -7.7% | 22,250 | -39.0% | 0.01% | -11.1% |
| Q3 2020 | $626,000 | -63.3% | 36,495 | -47.0% | 0.01% | -69.0% |
| Q2 2020 | $1,704,000 | +945.4% | 68,876 | +236.1% | 0.03% | +866.7% |
| Q2 2019 | $163,000 | +32.5% | 20,494 | +104.8% | 0.00% | -50.0% |
| Q2 2018 | $123,000 | -10.2% | 10,009 | +12.5% | 0.01% | -25.0% |
| Q1 2018 | $137,000 | – | 8,896 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |